Uncovering the Mutation Behind SKD3 Enzyme and MGC7 Disease
Scientists have discovered a new mutation of the SKD3 enzyme that could lead to advances in treating MGCA7, a rare, deadly genetic disease. The mutation, which was discovered in a family of five living in Canada, has the potential to help millions of people who suffer from the disease. The research team, led by Dr. William Binder, found that the mutated SKD3 enzyme could be used to interfere with the progression of the disease, potentially leading to a cure. This discovery marks a major breakthrough in the field of genetic diseases and could lead to treatments that improve and extend the lives of those affected.
source: Phys.org